Partnership to advance protein sciences in drug discovery 

""

ELRIG UK has partnered with The Protein Society (TPS) to provide forums for the advancement of research into protein structure, function, design and applications.  

The partners will collaborate to deliver a joint conference on ‘Protein Sciences in Drug Discovery’, bringing together their respective communities to focus on the application of emerging areas of protein science to the challenges of drug discovery. 

Working together will enable the organisations to create a productive interdisciplinary forum that incorporates diverse research interests and experimental approaches, offering their drug discovery and protein science communities the opportunity to connect and share ideas. 

Protein Sciences in Drug Discovery 2024 takes place from 18–19 November at Hinxton Hall Conference Centre in Cambridge, UK. 

The interactive event will bring together scientists from academia, pharma, biotech and CROs to discuss high-throughput methods for protein expression, approaches for generation of antigens for antibody and vaccine discovery, analytical techniques to interrogate protein quality, and the application of cryogenic electron microscopy (cryo-EM) for druggability, as well as sequence-based predictive methods. 

The free-to-attend conference also includes poster presentations, networking sessions as well as a vendor exhibition, and offers travel bursary opportunities for early career professionals. 

Melanie Leveridge, Vice President Discovery Biology at AstraZeneca and Chair of ELRIG UK, said: “Our organisations share a unifying goal — to provide a platform that enables academia and industry to exchange knowledge that supports innovation and fosters collaboration across the life science community.” 

Professor Elizabeth Meiering, President of The Protein Society, and Professor at University of Waterloo, said: “Bringing together leading experts from complementary disciplines provides an exceptional opportunity to communicate the latest advances and techniques in protein science and how to apply them to support drug discovery.” 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free